Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOC Trial: Liposomal Bupivacaine for Rebound Pain in Orthopedic Surgery
NCT07606911Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Oct 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in acute pain, sponsored by Shanghai Sixth People's Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07606911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07606911.